MedTrace Logo

Incidence of Hypoglycaemia Events in Patients With Stable Insulin-treated Type 2 Diabetes Mellitus Based on Continuous Glucose Monitoring

NCT05461716 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2022-07-18

No results posted yet for this study

Summary

Certain groups of patients with Type 2 Diabetes Mellitus (T2DM) appear to have higher risk of hypoglycaemia. Periodic use of Continuous Glucose Monitoring (CGM), has been suggested as a method to detect hypoglycaemia events in certain subgroups of patients with high risk of hypoglycaemia.

The aim of the present study is to contribute to the identification of subgroups of T2DM patients with high risk of hypoglycemia events, based on periodic use of Continuous Glucose Monitoring (CGM).

Conditions

  • Diabetes Mellitus Type 2 With Hypoglycemia

Interventions

DEVICE

periodic use of Continuous Glucose Monitoring (CGM)

Identification of hypoglycaemia events, based on use of Continuous Glucose Monitoring (CGM) for at least 14days, in subgroups of T2DM patients with high risk of hypoglycaemia

Sponsors & Collaborators

  • Centre for Research and Technology Hellas

    collaborator OTHER

  • University of Ioannina

    collaborator OTHER

  • George E. Dafoulas

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2023-03-31
FDA Device
Yes

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05461716 on ClinicalTrials.gov